Skip to Main Content

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Conditions

Diseases of the Respiratory Systems | COVID-19 Inpatient

Phase COVID-III

What is the purpose of this trial?

The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens with respect to the normalization of temperature and oxygen saturation through Day 14 in participants with severe coronavirus disease (COVID-19).

  • Trial with
    Gilead Sciences
  • Start Date
    03/20/2020
  • End Date
    06/29/2020
Trial Image

For more information about this study, contact:

Laurie Andrews

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/17/2020
  • Study HIC
    #2000027732